Literature DB >> 23273

A relationship between the metabolism of bumetanide and its diuretic activity in the rat.

S C Halladay, D E Carter, I G Sipes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 23273

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  8 in total

Review 1.  Integration of animal pharmacokinetic and pharmacodynamic data in drug safety assessment.

Authors:  D A Smith
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

Review 3.  Clinical pharmacology of loop diuretics.

Authors:  D C Brater
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Bumetanide inhibits rapid kindling in neonatal rats.

Authors:  Andréy Mazarati; Don Shin; Raman Sankar
Journal:  Epilepsia       Date:  2009-02-26       Impact factor: 5.864

5.  Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments.

Authors:  S H Lee; M G Lee; N D Kim
Journal:  J Pharmacokinet Biopharm       Date:  1994-02

Review 6.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

7.  In vitro Metabolism of Bumetanide.

Authors:  G Grosa; F Viola; O Caputo; G Biglino
Journal:  Pharm Res       Date:  1984-11       Impact factor: 4.200

8.  A Pilot Randomized, Controlled, Double-Blind Trial of Bumetanide to Treat Neonatal Seizures.

Authors:  Janet S Soul; Ann M Bergin; Christian Stopp; Breda Hayes; Avantika Singh; Carmen R Fortuno; Deirdre O'Reilly; Kalpathy Krishnamoorthy; Frances E Jensen; Valerie Rofeberg; Min Dong; Alexander A Vinks; David Wypij; Kevin J Staley
Journal:  Ann Neurol       Date:  2020-12-03       Impact factor: 10.422
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.